Results 161 to 170 of about 325,721 (301)
Blurred lines: Primary metabolic machinery coopted for specialized metabolism in tomato trichomes. [PDF]
Kerwin RE.
europepmc +1 more source
This review explores how alternative invertebrate and small‐vertebrate models advance the evaluation of nanomaterials across medicine and environmental science. By bridging cellular and organismal levels, these models enable integrated assessment of toxicity, biodistribution, and therapeutic performance.
Marie Celine Lefevre +3 more
wiley +1 more source
California poppy (Eschscholzia californica), the Papaveraceae golden girl model organism for evodevo and specialized metabolism. [PDF]
Becker A, Yamada Y, Sato F.
europepmc +1 more source
Oxygen and ROS Delivery for Infected Wound Healing and Future Prospects
Bacterial infection is a major driver of delayed wound healing and postsurgical readmissions; with rising antibiotic resistance, solid peroxide–releasing biomaterials offer sustained delivery of ROS/O2 for antimicrobial control and microenvironmental modulation.
Ayden Watt +7 more
wiley +1 more source
Editorial: Untapped metabolic diversity in legume-characteristic pathways
Mehran Dastmalchi +2 more
doaj +1 more source
Deciphering Chemical Mediators Regulating Specialized Metabolism in a Symbiotic Cyanobacterium. [PDF]
Krumbholz J +7 more
europepmc +1 more source
xx xx. ABSTRACT Stimuli‐responsive nanomaterials capable of spatiotemporal control over drug release are of nanocomposite patch (“e‐Medi‐Patch”) engineered from biodegradable polycaprolactone (PCL), graphene nanoplatelets, and a redox‐active therapeutic, niclosamide. The hierarchical composite integrates π‐π interactions between aromatic drug molecules
Santosh K. Misra +7 more
wiley +1 more source
Redesigning plant specialized metabolism with supervised machine learning using publicly available reactome data. [PDF]
Lim PK, Julca I, Mutwil M.
europepmc +1 more source
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source

